Europe PMCopen access
Safety and Effectiveness of Inebilizumab in Patients with Neuromyelitis Optica Spectrum Disorder: Interim Analysis of a Post-marketing Surveillance in Japan
Safety, Glucocorticoids, Effectiveness, Relapse, Post-marketing Surveillance, Neuromyelitis Optica Spectrum Disorder
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 1133156
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.